Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Lactoferrin in HPV Clearance
IRCT20231004059608N1Phase 3Completed
- Sponsor
- Pasteur Institute of Iran
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of lactoferrin in human papillomavirus infection, sponsored by Pasteur Institute of Iran. Primary endpoint: HPV clearance. Started May 2024; status: completed.
02
Drugs
lactoferrin
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on IRCT20231004059608N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231004059608N1.